Cencora Inc. (COR)

Name: Cencora Inc. (COR) — Historie der Geschäftszahlen
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historie von Umsatz, Gewinn und Cashflow aus den offiziellen Geschäftsberichten.

Health Care · Wall Street (USA) · Zuletzt aktualisiert: 2026-08-16

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S.

Kennzahlen

Marktkapitalisierung: $60 billion
Umsatz (Geschäftsjahr endet 2025-09-30): $321.3B
Jahresüberschuss: $1.6B
Bruttomarge: 3.2%
Nettomarge: 0.5%

Interaktive Charts und vollständige Abschlüsse ansehen → Bewertungsmodell (DCF) →

Gewinn- und Verlustrechnung (jährlich)

Gewinn- und Verlustrechnung	TTM → 2026-06-30	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
Gesamtumsatz	$332.8B	$321.3B	$294.0B	$262.2B	$238.6B	$214.0B	$189.9B	$179.6B	$167.9B	$153.1B	$146.8B	$136.0B	$119.6B	$88.0B	$79.5B	$80.2B	$78.0B	$71.8B	$70.2B	$66.1B	$61.2B
Bruttoergebnis	$12.3B	$10.1B	$8.7B	$7.8B	$7.6B	$6.3B	$4.8B	$4.5B	$4.1B	$4.1B	$3.8B	$3.2B	$2.8B	$2.3B	$2.5B	$2.4B	$2.2B	$2.0B	$1.9B	$2.2B	$2.1B
Bruttomarge %	3.7%	3.2%	3.0%	3.0%	3.2%	2.9%	2.5%	2.5%	2.5%	2.7%	2.6%	2.4%	2.3%	2.6%	3.2%	3.0%	2.9%	2.8%	2.8%	3.3%	3.4%
Betriebsergebnis (EBIT)	$4.4B	$3.6B	$3.0B	$2.4B	$2.8B	$2.7B	$2.0B	$1.9B	$1.7B	$2.0B	$1.7B	$1.3B	$1.2B	$989M	$1.3B	$1.2B	$1.1B	$899M	$824M	$787M	$728M
Operative Marge %	1.3%	1.1%	1.0%	0.9%	1.1%	1.2%	1.1%	1.0%	1.0%	1.3%	1.1%	1.0%	1.0%	1.1%	1.6%	1.5%	1.4%	1.2%	1.2%	1.2%	1.2%
Jahresüberschuss	$2.6B	$1.6B	$1.5B	$1.7B	$1.7B	$1.5B	($3.4B)	$855M	$1.7B	$414M	$1.4B	($135M)	$276M	$434M	$719M	$707M	$637M	$503M	$251M	$469M	$468M
Nettomarge %	0.8%	0.5%	0.5%	0.7%	0.7%	0.7%	-1.8%	0.5%	1.0%	0.3%	1.0%	-0.1%	0.2%	0.5%	0.9%	0.9%	0.8%	0.7%	0.4%	0.7%	0.8%
EBITDA	—	$3.7B	$3.4B	$3.4B	$3.1B	$2.9B	($4.7B)	$1.7B	$1.9B	$1.5B	$1.9B	$631M	$939M	$1.1B	$1.4B	$1.3B	$1.2B	$978M	$929M	$960M	$846M
Ergebnis je Aktie (EPS)	$13.46	$7.96	$7.53	$8.53	$8.04	$7.39	$-16.60	$4.04	$7.53	$1.87	$6.32	$-0.62	$1.17	$1.84	$2.80	$2.54	$2.22	$1.66	$0.77	$1.25	$1.13
Ausstehende Aktien (Mio.)	—	195M	200M	205M	211M	208M	205M	212M	220M	222M	226M	218M	235M	235M	257M	278M	287M	303M	325M	376M	415M

Quelle: veröffentlichte Unternehmensberichte (SEC). Bitte prüfen Sie die Zahlen vor Verwendung auf SEC EDGAR.

Bilanzen, Cashflow-Rechnungen, Quartalsdaten und alle Kennzahlen finden Sie im interaktiven Viewer für COR. /companies/us/COR

Ähnliche Unternehmen

Die Informationen auf dieser Website dienen ausschließlich Bildungs- und Informationszwecken und stellen keine Anlageberatung dar. Es werden keine Kursziele und keine Anlageurteile veröffentlicht.

English version →Alle Aktien

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.